Evidence map›Paper›PMID 40738668›Full record

ArticlePhotochemistry and photobiology

Germicidal potential and skin compatibility of an innovative UVC phototherapy device emitting at 234 nm.

Zheng Tang, David Welch, Manuela Buonanno, Mark Gerber, David J Brenner

Abstract read
In one paragraph

Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zheng TangCenter for Radiological Research, Columbia University Medical Center, New York, New York, USA.
David WelchCenter for Radiological Research, Columbia University Medical Center, New York, New York, USA.ORCID 0000-0003-2784-496X
Manuela BuonannoCenter for Radiological Research, Columbia University Medical Center, New York, New York, USA.ORCID 0000-0002-3455-3602
Mark GerberSpectrum Medical Technologies, Vero Beach, FL, USA.
David J BrennerCenter for Radiological Research, Columbia University Medical Center, New York, New York, USA.ORCID 0000-0002-0926-1210

Funding

Columbia University Urban Tech AwardEmpire State DevelopmentFar UV FoundationNIOSH CDC HHS R01OH012312Open Philanthropy / Good Ventures Foundation
6 · The paper itself

Abstract

Chronic wounds are a major healthcare issue affecting more than 10 million Americans each year, with a 5-year survival similar to cancer and costing the healthcare system billions of dollars annually. Current solutions, such as antiseptics and antibiotics, can be toxic to cells or contribute to the development of antibiotic-resistant strains of bacteria. Exposure to germicidal ultraviolet radiation (GUV) at 254 nm has been reported as an effective method for chronic wound management. However, concerns about the health hazards from exposure to 254 nm radiation have limited its use for wound management applications. In contrast, wavelengths of ultraviolet radiation in the range of 200-235 nm have exhibited similar germicidal ability but with a lower penetration range in tissue, potentially making those wavelengths better suited for chronic wound disinfection. In this study, a novel phototherapy device emitting principally at 234 nm was used to assess the killing efficacy against Methicillin-resistant Staphylococcus aureus (MRSA). Potential health hazards from exposure using the device were evaluated using a 3D human skin model. The ultraviolet exposure device tested in this study shows promise for effective decontamination of chronic nonhealing wounds without associated health hazards.

Indexed as

Methicillin-Resistant Staphylococcus aureusSkinUltraviolet RaysUltraviolet TherapyDisinfectionHumansantimicrobialcyclobutane pyrimidine dimersfar‐UVCLEDMRSAsurgical site infectionultraviolet radiation

Identifiers

PMID40738668
PMCPMC13005286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.